Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Vaccines against sexually transmitted infections: The way forward
Ist Teil von
Vaccine, 2014-03, Vol.32 (14), p.1630-1637
Ort / Verlag
Netherlands: Elsevier Ltd
Erscheinungsjahr
2014
Quelle
MEDLINE
Beschreibungen/Notizen
[...]mathematical modeling will be important to predict the population impact of varying levels of vaccine efficacy, incorporating potential differences by sex and HSV-1 serostatus.\n There is no indication in the recommendations that any particular STI has been selected for emphasis or that any "expert" in this group has unduly influenced the recommendations. Acknowledgements Participants of the 2013 STI Vaccine Technical Consultation: Patrik Bavoil (University of Maryland, Baltimore, USA); Gail Bolan (Centers for Disease Control and Prevention, USA); Rebecca Brotman (University of Maryland School of Medicine, USA); Nathalie Broutet (World Health Organization, Switzerland); Robert C. Brunham (British Columbia Centre for Disease Control, Canada); Caroline E. Cameron (University of Victoria, Canada); Jane Carlton (New York University, USA); Venkatraman Chandra-Mouli (World Health Organization, Switzerland); Xiang-Sheng Chen (Chinese Academy of Medical Sciences and Peking Union Medical College, China); Zvavahera (Mike) Chirenje (University of Zimbabwe, Zimbabwe); Carolyn Deal (National Institute of Allergy and Infectious Diseases, USA); Betty Dodet (Dodet Biosciences, France); Peter Figueroa (University of the West Indies, Jamaica); Uli Fruth (World Health Organization, Switzerland); Geoffrey Garnett (Bill and Melinda Gates Foundation, USA); Khalil Ghanem (Johns Hopkins University School of Medicine, USA); Sami Gottlieb (World Health Organization, Switzerland); Patti Gravitt (Perdana University Graduate School of Medicine, Malaysia); Gerardo Guillen (Center for Genetic Engineering and Biotechnology, Cuba); Sarah Hawkes (University College London, UK); Annika Hofstetter (Columbia University Medical Center, USA); Walter Jaoko (International Centre for Reproductive Health, Kenya); Ann E. Jerse (Uniformed Services University of the Health Sciences, USA); Christine Johnston (University of Washington, USA); Nicola Low (University of Bern, Switzerland); David Mabey (London School of Hygiene and Tropical Medicine, UK); Noni MacDonald (Dalhousie University, Canada); Fred Mhalu (Muhimbili University of Health and Allied Sciences, Tanzania); André Meheus (University of Antwerpen, Belgium); Lori Newman (World Health Organization, Switzerland); Jacques Ravel (University of Maryland School of Medicine, USA); Helen Rees, Consultation Chairperson (Wits Reproductive Health and HIV Institute, University of the Witwatersrand, South Africa); Anne M. Rompalo (Johns Hopkins University School of Medicine, USA); Kenneth L. Rosenthal (McMaster University, Canada); Susan Rosenthal (Columbia University Medical Center, USA); Michael W. Russell (University of Buffalo, USA); Robin Shattock (Imperial College London, UK); Lawrence Stanberry (Columbia University Medical Center, USA); Yot Teerawattananon (Department of Health Ministry of Public Health, Thailand); Peter Timms (Queensland University of Technology, Australia); Daisy Vanrompay (Ghent University, Belgium); Andrea Vicari (World Health Organization/Pan American Health Organization, Costa Rica); Teodora Wi (World Health Organization, Switzerland).